Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Moderna 0.145, BioNTech 0.114.
Moderna vs BioNTech: Revenue Comparison
Moderna (MRNA) and BioNTech (BNTX) are peers in Vaccines. Moderna reported revenue of $145M as of Q2 2026, compared with $114M for BioNTech. Moderna leads on revenue.
Moderna's gross margin is 35.9% versus 8.1% for BioNTech. Moderna's net margin is -539.3% versus -777.3% for BioNTech.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Moderna, BioNTech.| Metric | Moderna | BioNTech |
|---|---|---|
| Market Cap | - | - |
| Revenue | $145.00M | $114.00M |
| Cost of Revenue | $93.00M | $105.00M |
| Gross Profit | $52.00M | $9.00M |
| Operating Income | $-815.00M | $-1.02B |
| Net Income | $-782.00M | $-886.00M |
| R&D Expense | $651.00M | $595.00M |
| Earnings Per Share | -$1.96 | -$3.5 |
| Gross Margin | 35.9% | 8.1% |
| Operating Margin | -562.1% | -897.8% |
| Net Profit Margin | -539.3% | -777.3% |
| Free Cash Flow | $-563.00M | $-48.00M |
| Cumulative Free Cash Flow | $7.37B | $19.56B |
| Operating Cash Flow | $-526.00M | $12.00M |
| Cash & Equivalents | $1.72B | $10.52B |